Less Ads, More Data, More Tools Register for FREE

Pin to quick picksToyota Motor Regulatory News (TYT)

Share Price Information for Toyota Motor (TYT)

Share Price is delayed by 15 minutes
Get Live Data
2,804.30632    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.00 (0.00%)
Market Cap:
TYT Live PriceLast checked at - London Stock Exchange

Intraday Toyota Motor Share Chart

Stabilisation Notice

Today 09:49

RNS Number : 2155J
J.P. Morgan Securities PLC.
22 June 2026
 

22nd June 2026

Not for distribution, directly or indirectly, in or into the United States or any jurisdiction in which such distribution would be unlawful.

Toyota Motor Corporation

 

Pre-stabilisation Period Announcement

 

J.P. Morgan Securities PLC, (contact: Robert Chambers +442071342468) hereby gives notice, as Stabilisation Coordinator, that the Stabilising Manager(s) named below may stabilise the offer of the following securities in accordance with Commission Delegated Regulation EU/xxx/2016 under the Market Abuse Regulation (EU/596/2016).

The securities:

Issuer:

Toyota Motor Corporation

Obligor (if any):

N/A

Aggregate nominal amount:

EUR 4yrFXD - 500M WNG

EUR 8yrFXD - 500M WNG

Description:

EUR RegS Registered Senior Unsecured FXD notes

 

Listing: Singapore Exchange Securities Trading Limited (SGX-ST)

Offer price:

TBC

Other offer terms:

EUR 100k x 1k

Stabilisation: Relevant Stabilisation regulation applies 

Stabilisation Manager(s):

J.P. Morgan Securities PLC (Stabilisation coordinator)

BOFA Securities (Stabilisation manager)

Morgan Stanley (Stabilisation manager)

Barclays (Stabilisation manager)

BNP Paribas (Stabilisation manager)

Stabilisation period expected to start on:

22nd June 2026

Stabilisation period expected to end no later than:

22nd July 2026

Existence, maximum size and conditions of use of overallotment facility:

The Stabilisation Manager(s) may over-allot the securities in an amount not exceeding 5% of the aggregate nominal amount stated above.

Stabilisation trading venue:

Over the counter, TBC

 

In connection with the offer of the above securities, the Stabilising Manager(s), or persons acting on behalf of the Stabilising Manager(s) may over-allot the securities, provided that the aggregate principal amount of the securities allotted does not exceed 105 percent of the aggregate principal amount of the securities, or effect transactions with a view to supporting the market price of the securities at a level higher than that which might otherwise prevail. However, stabilisation may not necessarily occur and any stabilisation action, if begun, may cease at any time, but it must end no later than the earlier of 30 days after the issue date of the securities and 60 days after the date of allotment of the securities.

This announcement is for information purposes only and does not constitute an invitation or offer to underwrite, subscribe for or otherwise acquire or dispose of any securities of the Issuer in any jurisdiction.

This announcement and the offer of the securities to which it relates are only addressed to and directed at persons outside the United Kingdom and persons in the United Kingdom who have professional experience in matters related to investments or who are high net worth persons within Article 12(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 and must not be acted on or relied on by other persons in the United Kingdom.

In addition, if and to the extent that this announcement is communicated in, or the offer of the securities to which it relates is made in, any EEA Member State that has implemented Directive 2003/71/EC (together with any applicable implementing measures in any Member State, the "Prospectus Directive") before the publication of a prospectus in relation to the securities which has been approved by the competent authority in that Member State in accordance with the Prospectus Directive (or which has been approved by a competent authority in another Member State and notified to the competent authority in that Member State in accordance with the Prospectus Directive), this announcement and the offer are only addressed to and directed at persons in that Member State who are qualified investors within the meaning of the Prospectus Directive (or who are other persons to whom the offer may lawfully be addressed) and must not be acted on or relied on by other persons in that in that Member State

This announcement is not an offer of securities for sale into the United States. The securities have not been, and will not be, registered under the United States Securities Act of 1933 and may not be offered or sold in the United States absent registration or an exemption from registration. There will be no public offer of securities in the United States.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
STAEAPKAALKKEEA
Date   Source Headline
22nd Apr 20258:00 amRNSRegarding Certain Media Reports
22nd Apr 20258:00 amRNSStatus and Completion of the Repurchase of Shares
3rd Apr 20258:00 amRNSRepurchase of Shares of our Common Stock
24th Mar 20258:00 amRNSIntroduction of Share-Based Compensation Plan
17th Mar 20258:00 amRNSNotification of Change in Status of Subsidiary
5th Mar 20258:00 amRNSRepurchase of Shares of our Common Stock
3rd Mar 20258:00 amRNSIntroduction of Shareholder Benefit Program
27th Feb 202510:00 amRNSprogress report on recurrence prevention measures
25th Feb 20259:30 amRNSNotification of Change of Representative Directors
25th Feb 20259:30 amRNSNotification of changes to Executive Structure
25th Feb 20259:30 amRNSTransition to an Audit and Supervisory Committee
5th Feb 20258:00 amRNSFY2025 3rd Quarter Financial Results Presentation
5th Feb 20258:00 amRNSNotification of Change in Status of Subsidiary
5th Feb 20258:00 amRNSFY2025 3rd Quarter Financial Summary
5th Feb 20258:00 amRNSRepurchase of Shares of our Common Stock
8th Jan 20258:00 amRNSRepurchase of Shares of our Common Stock
4th Dec 20248:00 amRNSRepurchase of Shares of our Common Stock
29th Nov 20248:00 amRNSFinancial Statements (FY2025 First Half)
29th Nov 20248:00 amRNSSummary of Fist Half Securities Report
25th Nov 20248:00 amRNSProgress Report on Recurrence Prevention Measures
6th Nov 20249:30 amRNSFY2025 First Half Financial Results Presentation
6th Nov 20248:00 amRNSInterim Dividends and Dividend Forecast Revision
6th Nov 20248:00 amRNSFY2025 First Half Finanacial Summary
5th Nov 20248:00 amRNSRepurchase of Shares of our Common Stock
3rd Oct 20248:00 amRNSRepurchase of Shares of our Common Stock
25th Sep 20248:00 amRNSResults of Share Repurchase(ToSTNeT-3)
24th Sep 20249:00 amRNSShare Repurchase (ToSTNeT-3 and Limit Increase)
4th Sep 20248:00 amRNSRepurchase of Shares of our Common Stock
27th Aug 20248:00 amRNSResults of Repurchase Through Tender Offer
9th Aug 202411:41 amRNSSubmission report on measure to prevent recurrence
9th Aug 20248:00 amRNSCorrective Order to Certification Applications
5th Aug 20248:00 amRNSRepurchase of Shares of our Common Stock
1st Aug 20248:00 amRNSFY2025 First Quarter Finanacial Summary
31st Jul 202410:04 amRNSCorrection Order to Certification Applications
23rd Jul 20248:00 amRNSRepurchase of Shares Through Tender Offer
5th Jul 20248:00 amRNSCompletion of Investigation
3rd Jul 20248:00 amRNSRepurchase of Shares of our Common Stock
25th Jun 202410:00 amRNSSummary of Annual Securities Report
25th Jun 20249:00 amRNSCorporate Governance Report
19th Jun 20248:00 amRNSVoting Results of General Shareholders' Meeting
19th Jun 20248:00 amRNSResolutions Adopted at Shareholders’ Meeting
5th Jun 20248:00 amRNSRepurchase of Shares of our Common Stock
3rd Jun 20248:00 amRNSInvestigation Regarding Certification Applications
13th May 20248:00 amRNSNotice of Convocation
8th May 20248:31 amRNSDisposition of Treasury Stock
8th May 20248:25 amRNSRetirement of Treasury Stock
8th May 20248:10 amRNSRepurchase of Shares of our Common Stock
8th May 20248:06 amRNSDistribution of Dividends from Surplus
8th May 20248:00 amRNSOpinion of the Board of Directors
8th May 20248:00 amRNSHolding of Ordinary General Shareholders’ Meeting

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.